Gray v. Takeda Pharmaceuticals America Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Gray v. Takeda Pharmaceuticals America Inc

Sort by

Viewing results 1‒25 of 154

Global Economy
Business leaders warn that three-decade era of globalisation is ending
...“Companies are saying I need my production closer to my customers,” said Jonathan Gray, president of Blackstone Group....
May 22, 2022
Coronavirus
Coronavirus: J&J talking to US regulators about rare neurological side effect of vaccine - as it happened
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
US opioid epidemic
US sues Walmart alleging role in country’s opioid crisis
...Prosecutors initially focused on high-prescribing doctors and on the pharmaceutical companies that manufactured and marketed the opioids....
December 22, 2020
Companies
Prospering in the pandemic: 2020’s top 100 companies
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
January 1, 2021
News in-depthPharmaceuticals sector
Crispr puts first human in-body gene editing to test
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
January 7, 2020
Due Diligence
Silver Lake: inside the rise of Egon Durban Premium content
...In private, Durban has pointed to actions taken by big pharmaceutical companies as evidence that a vaccine will come sooner rather than later....
June 4, 2020
FT Live
Innovative Lawyers Awards North America
Celebrating innovations from both law firms and in-house teams in the region
Monday, 9 DecemberGotham Hall, Broadway, New York, NY, USA
FT SeriesCompanies prospering in the pandemic
Prospering in the pandemic: the top 100 companies
...Alistair Gray 25....
June 19, 2020
Jonathan Guthrie
The fallacy behind the rise of passive fund management
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
January 15, 2020
Law
Top 10 individuals: winner’s mission to share medical data
...In 2015, he advised Mylan on a successful defence against a hostile bid by Teva Pharmaceuticals....
December 10, 2019
US & Canadian companies
Japan’s Renesas to acquire US rival IDT in $7.2bn deal
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
September 11, 2018
News in-depthWeek in Review
Week in review, March 31
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
March 30, 2018
Mergers & Acquisitions
Praxair sells $6bn in European assets to Japan’s Taiyo
...The combined value of those deals — which include Takeda Pharmaceutical’s ¥7tn planned takeover of Shire — was around ¥11.7tn....
July 5, 2018
FirstFT
Daily briefing: Trump-Macron bromance, Comcast, Takeda m&ania, #MeToo in China
...Separately, Japan’s Takeda Pharmaceutical has reached a preliminary agreement to buy Irish drugmaker Shire for about £46bn, a deal that could spark a renewed wave of “big pharma” deals....
April 25, 2018
News in-depthCurrencies
Global M&A activity hits new high
...Corporate giants including US cable group Comcast, wireless provider T-Mobile and Japan’s pharmaceutical maker Takeda reached for M&A to head off competitive threats and expand their businesses....
September 28, 2018
News in-depthUS & Canadian companies
MAmazon makes its move in healthcare
...When Amazon bought a big stake in drugstore.com in 1999, Jeff Bezos thought he could do for pharmaceuticals what he had done for books, stealing market share from bricks-and-mortar pharmacies and bringing...
January 31, 2018
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
News in-depthBanks
Record ‘megadeals’ push global takeovers beyond $1.2tn
...In the latest sign of how eager boardrooms are sparking a record number of “megadeals”, Japan’s top drugmaker Takeda revealed it was weighing a $40bn takeover of Irish rival Shire....
March 29, 2018
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
Health sector
Hikma Pharma dims generics outlook again after May cut
...Separately, Hikma disclosed on Thursday that it will expand its licensing and distribution pact with Japan’s Takeda Pharmaceuticals that will add new products to its Middle East and North Africa portfolio...
August 17, 2017
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
US politics & policy
Big US pharma dealmaking plunges to five-year low
...Thomas Sheehan, head of global healthcare at Bank of America Merrill Lynch, said despite the slowdown the fundamentals for dealmaking remained unchanged and activity was bound to pick up again....
June 12, 2017
Pharmaceuticals sector
Health care stocks fall after Trump comments on drug pricing
...Cancer drug maker Takeda Pharmaceutical, fell 2.6 per cent following Trump’s comments....
January 12, 2017
Special ReportFT Health: Vaccines
Demands of disease drive vaccine science
..., the pharmaceutical company....
April 18, 2017
US politics & policy
Drug stocks tumble as Trump singles out pharma companies
...In Japan, Takeda Pharmaceutical slid 2.7 per cent, Astellas Pharma fell 3.9 per cent and Shionogi sank 3.7 per cent on Thursday morning, while in Australia biotech company CSL Ltd dropped 1.4 per cent and...
January 12, 2017
News in-depthWeek in Review
Week in Review, December 3
...The Canadian pharmaceuticals group had been in negotiations to sell its stomach-and-bowel unit, Salix, to Takeda, Japan’s largest drugmaker, for roughly $10bn....
December 2, 2016
News in-depthUK companies
GSK and AstraZeneca prescribe different treatments
...For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical year....
January 3, 2016

Previous pagePage 1 of 7Next page